Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx

Am J Otolaryngol. 1994 Jul-Aug;15(4):250-7. doi: 10.1016/0196-0709(94)90091-4.
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Carcinoma in Situ / mortality
  • Carcinoma in Situ / pathology
  • Carcinoma in Situ / therapy*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Glottis*
  • Humans
  • Laryngeal Neoplasms / mortality
  • Laryngeal Neoplasms / pathology
  • Laryngeal Neoplasms / therapy*
  • Laryngectomy
  • Laser Therapy
  • Male
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy*
  • Neoplasm Staging
  • Radiation Injuries / epidemiology
  • Radiation Injuries / etiology
  • Radiation Injuries / therapy
  • Radiotherapy Dosage
  • Survival Rate
  • Time Factors
  • Vocal Cords